Michael H Weisman Selected Research

Neoplasms (Cancer)

1/2019	Patient Concerns and Perceptions Regarding Biologic Therapies in Ankylosing Spondylitis: Insights From a Large-Scale Survey of Social Media Platforms.
5/2016	Infection, malignancy, switching, biosimilars, antibody formation, drug survival and withdrawal, and dose reduction: what have we learned over the last year about tumor necrosis factor inhibitors in rheumatoid arthritis?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael H Weisman Research Topics

Disease

35	Rheumatoid Arthritis 01/2022 - 09/2002
21	Ankylosing Spondylitis 01/2022 - 05/2007
21	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 04/2004
14	Arthritis (Polyarthritis) 01/2021 - 02/2004
8	Inflammation (Inflammations) 01/2018 - 01/2009
7	Back Pain (Backache) 10/2021 - 08/2012
5	Infections 07/2020 - 09/2002
5	Pain (Aches) 01/2018 - 02/2006
4	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 09/2012
3	Axial Spondyloarthritis 10/2021 - 06/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 09/2020 - 01/2014
3	Disease Susceptibility (Diathesis) 01/2019 - 02/2010
3	Psoriatic Arthritis 09/2015 - 04/2005
3	Spondylarthropathies 04/2013 - 05/2007
3	Labyrinth Diseases 06/2009 - 10/2003
2	Genetic Risk Score 01/2022 - 01/2016
2	Hypertension (High Blood Pressure) 01/2022 - 09/2020
2	Osteoarthritis 12/2019 - 02/2006
2	Bronchiectasis 10/2019 - 06/2012
2	Crohn Disease (Crohn's Disease) 01/2019 - 01/2009
2	Spondylitis 01/2019 - 06/2013
2	Neoplasms (Cancer) 01/2019 - 05/2016
2	Necrosis 01/2018 - 12/2007
2	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2015 - 04/2005
2	Familial Mediterranean Fever (Periodic Disease) 01/2014 - 10/2012
2	Atherosclerosis 01/2014 - 04/2004
2	Lupus Nephritis 08/2012 - 11/2005
2	Joint Diseases (Joint Disease) 12/2009 - 01/2006
1	COVID-19 01/2021
1	Systemic Scleroderma (Systemic Sclerosis) 10/2020
1	Uveitis 09/2020
1	Osteoporosis 09/2020
1	Lymphoma (Lymphomas) 07/2020
1	Microscopic Polyangiitis 01/2020
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2020
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2019
1	Anterior Uveitis 01/2019
1	Hypersensitivity (Allergy) 01/2019

Drug/Important Bio-Agent (IBA)

18	AutoantibodiesIBA 01/2022 - 05/2007
9	HLA-B27 Antigen (HLA B27 Antigen)IBA 10/2021 - 07/2011
9	Anti-Citrullinated Protein AntibodiesIBA 01/2021 - 06/2012
9	Methotrexate (Mexate)FDA LinkGeneric 09/2015 - 11/2002
7	AntibodiesIBA 12/2019 - 12/2005
6	ametantrone (HAQ)IBA 02/2017 - 02/2004
5	cyclic citrullinated peptideIBA 04/2021 - 09/2013
5	Biological ProductsIBA 09/2020 - 12/2007
5	Monoclonal AntibodiesIBA 05/2016 - 01/2003
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2013 - 09/2002
4	Rheumatoid FactorIBA 01/2021 - 06/2012
4	Peptides (Polypeptides)IBA 12/2019 - 07/2011
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 06/2013
4	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 05/2015 - 08/2012
4	Biomarkers (Surrogate Marker)IBA 01/2014 - 08/2004
4	Adalimumab (Humira)FDA Link 02/2010 - 01/2003
3	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 01/2009
3	Vitamin D FDA LinkGeneric 01/2022 - 05/2009
3	hydroxide ionIBA 01/2022 - 05/2009
3	SteroidsIBA 04/2021 - 06/2009
3	Pharmaceutical PreparationsIBA 09/2020 - 01/2009
3	Immunoglobulin G (IgG)IBA 12/2019 - 12/2005
3	HLA-B Antigens (HLA-B)IBA 01/2019 - 08/2014
3	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2016 - 10/2003
3	CytokinesIBA 06/2013 - 06/2003
3	Infliximab (Remicade)FDA Link 05/2008 - 09/2002
3	Etanercept (Enbrel)FDA Link 07/2007 - 09/2002
2	Opioid Analgesics (Opioids)IBA 09/2020 - 01/2018
2	GlucocorticoidsIBA 01/2020 - 05/2012
2	Rituximab (Mabthera)FDA Link 01/2020 - 12/2007
2	Immunoglobulin A (IgA)IBA 12/2019 - 09/2013
2	HLA-DRB1 Chains (HLA DRB1)IBA 01/2019 - 01/2016
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2019 - 01/2009
2	AntigensIBA 01/2018 - 01/2017
2	C-Reactive ProteinIBA 10/2017 - 10/2013
2	EpitopesIBA 01/2017 - 01/2016
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2017 - 02/2016
2	rilonacept FDA Link 01/2014 - 10/2012
2	EnzymesIBA 09/2013 - 02/2006
2	Antimalarials (Antimalarial Agents)IBA 09/2012 - 04/2004
2	Interleukin-1 (Interleukin 1)IBA 02/2010 - 09/2002
2	Prednisone (Sone)FDA LinkGeneric 06/2009 - 11/2002
2	Abatacept (Orencia)FDA Link 12/2007 - 11/2006
2	Antirheumatic Agents (DMARD)IBA 04/2005 - 03/2004
1	25-hydroxyvitamin DIBA 01/2022
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021
1	LipidsIBA 01/2021
1	SolutionsIBA 10/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	P-2 (P 2)IBA 01/2020
1	Anti-Idiotypic AntibodiesIBA 12/2019
1	Protein Glutamine gamma Glutamyltransferase 2IBA 04/2019
1	Cardiolipins (Cardiolipin)IBA 04/2019
1	HLA-A Antigens (HLA-A)IBA 01/2019

Therapy/Procedure

18	Therapeutics 07/2020 - 11/2002
2	Biological Therapy 01/2019 - 09/2002
1	Contraception (Birth Control) 08/2020
1	Ambulatory Care (Outpatient Care) 07/2020
1	Remission Induction 01/2020
1	Traction 10/2019